2Health AI

Gene to Health Limited ([https://gene2h.com](https://gene2h.com)) have launched the G2H system embodying broad-spectrum disease-risk prediction models trained on health data from over one million people, which integrates DNA data, health check reports, and medical records to generate risk scores for over a thousand diseases. Its spin-off, 2Health AI Limited ([https://2health.cn](https://2health.cn)), has recently developed the world's first comprehensive multi-omics and AI-driven personal health digital twin platform, 2HEALTH AI (2HAI). It integrates genomic, metabolomic, physical-exam, clinical, wearable, home-device and lifestyle data into a continuously-updated personal health profile spanning the entire life cycle. Powered by the G2H system, plus an intelligent analytics engine and AI health advisors, 2HAI delivers lifelong health-data management, long-term risk assessment across hundreds of diseases, personalized recommendations, secondary report interpretation, lifestyle intervention, biological-age and life-expectancy estimation, and connection to medical services. The platform offer interfaces also to doctors and suppliers, helping connect them with individuals and families in a large ecosystem of healthcare products and services. The platform is already live at [2health.ai](https://2health.ai) and is being put into pilot use as Digital Public Infrastructure for Health (DPI-H) in the ASEAN market.